Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? (Q39665909)

13 September 2017

Altered levels of fecal chromogranins and secretogranins in IBS: relevance for pathophysiology and symptoms? (English)

1 reference

13 September 2017

0 references

1 reference

5

Magnus Simrén

1 reference

13 September 2017

Lena Ohman

1

1 reference

13 September 2017

Mats Stridsberg

series ordinal

2

1 reference

13 September 2017

Stefan Isaksson

series ordinal

3

1 reference

13 September 2017

Pernilla Jerlstad

series ordinal

4

1 reference

13 September 2017

language of work or name

English

0 references

publication date

10 January 2012

1 reference

The American Journal of Gastroenterology

13 September 2017

1 reference

13 September 2017

107

1 reference

13 September 2017

3

1 reference

13 September 2017

440-447

1 reference

https://scigraph.springernature.com/pub.10.1038/ajg.2011.458

13 September 2017

0 references

cites work

Relative importance of enterochromaffin cell hyperplasia, anxiety, and depression in postinfectious IBS.

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Increased rectal mucosal enteroendocrine cells, T lymphocytes, and increased gut permeability following acute Campylobacter enteritis and in post-dysenteric irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Mucosal immune activation in irritable bowel syndrome: gender-dependence and association with digestive symptoms.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

A controlled study of colonic immune activity and beta7+ blood T lymphocytes in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Activated mast cells in proximity to colonic nerves correlate with abdominal pain in irritable bowel syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Diarrhoea-predominant IBS patients show mast cell activation and hyperplasia in the jejunum.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Duodenal mastocytosis, eosinophilia and intraepithelial lymphocytosis as possible disease markers in the irritable bowel syndrome and functional dyspepsia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The role of psychological and biological factors in postinfective gut dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Milieu-induced, selective aggregation of regulated secretory proteins in the trans-Golgi network

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The chromogranins A and B: the first 25 years and future perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Secretogranin III binds to cholesterol in the secretory granule membrane as an adapter for chromogranin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Identification of a chromogranin A domain that mediates binding to secretogranin III and targeting to secretory granules in pituitary cells and pancreatic beta-cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Peptide Hormones as Tumor Markers in Neuroendocrine Gastrointestinal Tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Detection of pseudodiarrhoea by simple clinical assessment of intestinal transit rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Measurements of secretogranins II, III, V and proconvertases 1/3 and 2 in plasma from patients with neuroendocrine tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Measurements of chromogranin A, chromogranin B (secretogranin I), chromogranin C (secretogranin II) and pancreastatin in plasma and urine from patients with carcinoid tumours and endocrine pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The hospital anxiety and depression scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The SCL-90 and the MMPI: A Step in the Validation of a New Self-Report Scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

An Irritable Bowel Syndrome-Specific Symptom Questionnaire: Development and Validation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The MOS 36-ltem Short-Form Health Survey (SF-36)

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Gastrointestinal-specific anxiety: an important factor for severity of GI symptoms and quality of life in IBS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The Visceral Sensitivity Index: development and validation of a gastrointestinal symptom-specific anxiety scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The central role of gastrointestinal-specific anxiety in irritable bowel syndrome: further validation of the visceral sensitivity index.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Regulatory peptides from chromogranin A and secretogranin II: putative modulators of cells and tissues involved in inflammatory conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Granins as disease-biomarkers: translational potential for psychiatric and neurological disorders.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Abolishment of TNBS-induced visceral hypersensitivity in mast cell deficient rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The effect of a chromogranin A-derived peptide (CgA4-16) in the writhing nociceptive response induced by acetic acid in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Effects of a chromogranin-derived peptide (CgA 47-66) in the writhing nociceptive response induced by acetic acid in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

A role for chromogranin A (4-16), a vasostatin-derived peptide, on human colonic motility. An in vitro study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Effects of stressful life events on bowel symptoms: subjects with irritable bowel syndrome compared with subjects without bowel dysfunction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Evaluation of psychosomatic stress in children by measuring salivary chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

The effects of examination stress on salivary cortisol, immunoglobulin A, and chromogranin A in nursing students

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Changes in salivary physiological stress markers induced by muscle stretching in patients with irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Neonatal maternal separation alters stress-induced responses to viscerosomatic nociceptive stimuli in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Neonatal maternal deprivation triggers long term alterations in colonic epithelial barrier and mucosal immunity in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Plasma chromogranin A: a marker of serotonin release and of emesis associated with cisplatin chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Secretogranin II: molecular properties, regulation of biosynthesis and processing to the neuropeptide secretoneurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Transendothelial migration of leukocytes and signalling mechanisms in response to the neuropeptide secretoneurin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Secretogranin III directs secretory vesicle biogenesis in mast cells in a manner dependent upon interaction with chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Catestatin (CgA344-364) stimulates rat mast cell release of histamine in a manner comparable to mastoparan and other cationic charged neuropeptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

ECL-cell histamine mobilization in conscious rats: effects of locally applied regulatory peptides, candidate neurotransmitters and inflammatory mediators

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Pathogenesis of IBS: role of inflammation, immunity and neuroimmune interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Specific binding of a 125I-secretoneurin analogue to a human monocytic cell line

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Secretoneurin and chemoattractant receptor interactions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Immunological studies on the distribution of chromogranin A and B in endocrine and nervous tissues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Mast cell-dependent excitation of visceral-nociceptive sensory neurons in irritable bowel syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

Maternal deprivation affects the neuromuscular protein profile of the rat colon in response to an acute stressor later in life

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2011.458

21 January 2018

Identifiers

DOI

10.1038/AJG.2011.458

1 reference

Dimensions Publication ID

13 September 2017

0 references

1 reference